Desicorpinc
Delaware corporation · 1 known investors
DesiCorp develops advanced packaging and stabilization solutions for biopharmaceutical and therapeutic products, extending shelf-life without refrigeration to improve access in rural, remote, and emergency care settings. The company uses specialized materials and two-chambered packaging designs to preserve sensitive compounds during transport and storage in austere environments.
BiotechHealthtechNew Materials
Founders & leadership
BJ
Brett JanisCEO/CSO, Treasurer, and Co-founder
JK
Jonathan KopechekSecretary and Co-founder
MM
Michael MenzePresident and Co-founder
RS
Robert SaundersDirector
JK
Jonathan KopecheckExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.5MraisedJun 2026 · 12 investors · BiotechnologyRule 506(b)
▶$3.5MraisedJun 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael MenzeExecutive Officer, Director
- Jonathan KopecheckExecutive Officer, Director
- Brett JanisExecutive Officer, Director
- Robert SaundersDirector
- Offering amount
- $6M
- Amount sold
- $3.5M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJan 2026 · 15 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2026 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert SaundersDirector
- Michael MenzeExecutive Officer, Director
- Jonathan KopecheckExecutive Officer, Director
- Brett JanisExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.2M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.